| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49.0 days-63.0 days |
8 |
|
13.94 |
IU/g |
2.2 |
6.23 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
49832 |
461 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
13 |
|
7.73 |
ml/min/g |
0.51 |
1.84 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
44708 |
461 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
14 |
|
10.44 |
ml/min/g |
0.5 |
1.88 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46856 |
461 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
15 |
|
11.14 |
ml/min/g |
0.31 |
1.2 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46860 |
461 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
14 |
post-ischemic value/pre-ischemic value x 100% |
41.68 |
% |
4.12 |
15.43 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
47063 |
461 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
14 |
post-ischemic value/pre-ischemic value x 100% |
48.49 |
% |
4.72 |
17.67 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
47067 |
461 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
14 |
|
14.82 |
ml/min/g |
0.51 |
1.93 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46643 |
461 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
14 |
|
12.9 |
ml/min/g |
0.79 |
2.95 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46639 |
461 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
14 |
|
6.6 |
ml/min/g |
0.55 |
2.06 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46191 |
461 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49.0 days-63.0 days |
9 |
|
9.56 |
IU/g |
1.64 |
4.91 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
49838 |
461 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49.0 days-63.0 days |
6 |
|
11.43 |
IU/g |
0.72 |
1.77 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
45697 |
461 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
14 |
|
6.16 |
ml/min/g |
0.44 |
1.64 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46187 |
461 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49.0 days-63.0 days |
12 |
|
0.18 |
IU/g |
0.06 |
0.2 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
47432 |
461 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
13 |
|
5.8 |
ml/min/g |
0.47 |
1.7 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
44704 |
461 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
14 |
post-ischemic value/pre-ischemic value x 100% |
59.38 |
% |
3.7 |
13.86 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46052 |
461 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49.0 days-63.0 days |
13 |
|
0.17 |
IU/g |
0.04 |
0.14 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
47282 |
461 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49.0 days-63.0 days |
14 |
|
0.22 |
IU/g |
0.05 |
0.19 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
47290 |
461 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49.0 days-63.0 days |
6 |
|
11.83 |
IU/g |
0.85 |
2.09 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
45703 |
461 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
15 |
post-ischemic value/pre-ischemic value x 100% |
54.99 |
% |
5.6 |
21.67 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46056 |
461 |
| SS.BN-(D12Arb13-D12Rat79)/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49.0 days-63.0 days |
12 |
|
0.23 |
IU/g |
0.06 |
0.19 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
47424 |
461 |